// App-Quantinova.ai

EP432 : VALIDATION AND CLINICAL APPLICATION OF AN UNSUPERVISED ANALYSIS APPROACH TO MEASURABLE RESIDUAL DISEASE TESTING IN ACUTE MYELOID LEUKEMIA

Researchers

Presenter

  • Nicholas McCarthy

Principal Investigators

  • Justin Loke

  • Georgia Andrew

  • Aimee Jackson

  • Andrea Hodgkinson

  • John Mason

  • Christophe Roumier

  • Adriana Plesa

  • Florent Dumezy

  • Naeem Khan

  • Charles Craddock

  • Sylvie Freeman

Medical Centers

  • Laboratory of Hematology, Biology and Pathology Center,CHU of Lille,Lille,France

  • Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom

  • Laboratory of Hematology and Flow Cytometry,CHU Lyon-Sud Hospital, Hospices Civils de Lyon,Lyon,France

  • Centre for Clinical Haematology, University Hospital Birmingham, Birmingham, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • National Heart, Lung, and Blood Institute, NIH,Bethesda,United States

Locations

  • France

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved